105 related articles for article (PubMed ID: 23485813)
1. Cellular and ultra structural evidence for cytoskeletal localization of prolyl endopeptidase-like protein in neurons.
Morawski M; Nuytens K; Juhasz T; Zeitschel U; Seeger G; Waelkens E; Regal L; Schulz I; Arendt T; Szeltner Z; Creemers J; Rossner S
Neuroscience; 2013 Jul; 242():128-39. PubMed ID: 23485813
[TBL] [Abstract][Full Text] [Related]
2. Deletion of PREPl causes growth impairment and hypotonia in mice.
Lone AM; Leidl M; McFedries AK; Horner JW; Creemers J; Saghatelian A
PLoS One; 2014; 9(2):e89160. PubMed ID: 24586561
[TBL] [Abstract][Full Text] [Related]
3. PREPL, a prolyl endopeptidase-like enzyme by name only?--Lessons from patients.
Boonen K; Régal L; Jaeken J; Creemers JW
CNS Neurol Disord Drug Targets; 2011 May; 10(3):355-60. PubMed ID: 21222627
[TBL] [Abstract][Full Text] [Related]
4. Two novel deletions in hypotonia-cystinuria syndrome.
Régal L; Aydin HI; Dieltjens AM; Van Esch H; Francois I; Okur I; Zeybek C; Meulemans S; Van Mol C; Van Bruwaene L; Then SH; Jaeken J; Creemers J
Mol Genet Metab; 2012 Nov; 107(3):614-6. PubMed ID: 22796000
[TBL] [Abstract][Full Text] [Related]
5. Deletion of PREPL, a gene encoding a putative serine oligopeptidase, in patients with hypotonia-cystinuria syndrome.
Jaeken J; Martens K; Francois I; Eyskens F; Lecointre C; Derua R; Meulemans S; Slootstra JW; Waelkens E; de Zegher F; Creemers JW; Matthijs G
Am J Hum Genet; 2006 Jan; 78(1):38-51. PubMed ID: 16385448
[TBL] [Abstract][Full Text] [Related]
6. First cardiac manifestation of hypotonia-cystinuria syndrome.
Kılıç M; Ceylan AC; Örün UA; Kılıç E
Metab Brain Dis; 2018 Aug; 33(4):1375-1379. PubMed ID: 29627929
[TBL] [Abstract][Full Text] [Related]
7. Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia-cystinuria syndrome.
Chabrol B; Martens K; Meulemans S; Cano A; Jaeken J; Matthijs G; Creemers JW
J Med Genet; 2008 May; 45(5):314-8. PubMed ID: 18234729
[TBL] [Abstract][Full Text] [Related]
8. PREPL: a putative novel oligopeptidase propelled into the limelight.
Martens K; Derua R; Meulemans S; Waelkens E; Jaeken J; Matthijs G; Creemers JW
Biol Chem; 2006 Jul; 387(7):879-83. PubMed ID: 16913837
[TBL] [Abstract][Full Text] [Related]
9. 2p21 Deletions in hypotonia-cystinuria syndrome.
Eggermann T; Spengler S; Venghaus A; Denecke B; Zerres K; Baudis M; Ensenauer R
Eur J Med Genet; 2012 Oct; 55(10):561-3. PubMed ID: 22766003
[TBL] [Abstract][Full Text] [Related]
10. Trans-Golgi network morphology and sorting is regulated by prolyl-oligopeptidase-like protein PREPL and the AP-1 complex subunit μ1A.
Radhakrishnan K; Baltes J; Creemers JW; Schu P
J Cell Sci; 2013 Mar; 126(Pt 5):1155-63. PubMed ID: 23321636
[TBL] [Abstract][Full Text] [Related]
11. A substrate-free activity-based protein profiling screen for the discovery of selective PREPL inhibitors.
Lone AM; Bachovchin DA; Westwood DB; Speers AE; Spicer TP; Fernandez-Vega V; Chase P; Hodder PS; Rosen H; Cravatt BF; Saghatelian A
J Am Chem Soc; 2011 Aug; 133(30):11665-74. PubMed ID: 21692504
[TBL] [Abstract][Full Text] [Related]
12. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
[TBL] [Abstract][Full Text] [Related]
13. PREPL deficiency with or without cystinuria causes a novel myasthenic syndrome.
Régal L; Shen XM; Selcen D; Verhille C; Meulemans S; Creemers JW; Engel AG
Neurology; 2014 Apr; 82(14):1254-60. PubMed ID: 24610330
[TBL] [Abstract][Full Text] [Related]
14. PREPL deficiency: delineation of the phenotype and development of a functional blood assay.
Régal L; Mårtensson E; Maystadt I; Voermans N; Lederer D; Burlina A; Juan Fita MJ; Hoogeboom AJM; Olsson Engman M; Hollemans T; Schouten M; Meulemans S; Jonson T; François I; Gil Ortega D; Kamsteeg EJ; Creemers JWM
Genet Med; 2018 Jan; 20(1):109-118. PubMed ID: 28726805
[TBL] [Abstract][Full Text] [Related]
15. Multiomics Analyses Identify Proline Endopeptidase-Like Protein As a Key Regulator of Protein Trafficking, a Pathway Underlying Alzheimer's Disease Pathogenesis.
Duarte ML; Wang M; Gomes I; Liu C; Sharma A; Fakira AK; Gupta A; Mack SM; Zhang B; Devi LA
Mol Pharmacol; 2023 Jul; 104(1):1-16. PubMed ID: 37147110
[TBL] [Abstract][Full Text] [Related]
16. Corneal keratocytes: in situ and in vitro organization of cytoskeletal contractile proteins.
Jester JV; Barry PA; Lind GJ; Petroll WM; Garana R; Cavanagh HD
Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):730-43. PubMed ID: 8113024
[TBL] [Abstract][Full Text] [Related]
17. Hypotonia-cystinuria 2p21 deletion syndrome: Intrafamilial variability of clinical expression.
Towheed A; Hietanen CL; Kamath VG; Singh LN; Ho A; Engelstad K; Cornett K; Montes J; De Vivo D
Ann Clin Transl Neurol; 2021 Nov; 8(11):2199-2204. PubMed ID: 34612606
[TBL] [Abstract][Full Text] [Related]
18. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
20. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9.
Bussière T; Giannakopoulos P; Bouras C; Perl DP; Morrison JH; Hof PR
J Comp Neurol; 2003 Aug; 463(3):281-302. PubMed ID: 12820162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
